GABPA and breast cancer: Conceivably, the genetic methylation/deletion/mutation-mediated GABPA repression promotes an undifferentiated state, thereby leading to the development of stem cell trait, aggressive phenotype and therapy resistance of BC cells, and eventual disease progression.